NCT02183493View on ClinicalTrials.gov

Bioavailability of BI 1356 Administered With and Without Food to Healthy Male and Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

December 31, 2008

Conditions
Healthy
Interventions
DRUG

BI 1356

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02183493 - Bioavailability of BI 1356 Administered With and Without Food to Healthy Male and Female Subjects | Biotech Hunter | Biotech Hunter